Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 144

1.

Antiretroviral therapy does not affect response to chronic hepatitis C therapy in HIV-coinfected patients.

De Leon LB, Tovo CV, Kliemann DA, De Mattos AA, Feltrin AA, Pacheco LS, De Almeida PR.

J Infect Dev Ctries. 2016 Aug 2;10(7):762-9. doi: 10.3855/jidc.7542.

2.

Management of HCV-Associated Liver Cirrhosis.

Schneider MD, Sarrazin C.

Visc Med. 2016 Apr;32(2):96-104. doi: 10.1159/000445330. Epub 2016 Apr 8. Review.

PMID:
27413726
3.

Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts.

ANRS collaborative study group on hepatocellular carcinoma (ANRS CO22 HEPATHER, CO12 CirVir and CO23 CUPILT cohorts). Electronic address: stanislas.pol@aphp.fr.

J Hepatol. 2016 Oct;65(4):734-40. doi: 10.1016/j.jhep.2016.05.045. Epub 2016 Jun 7.

PMID:
27288051
4.

Direct-Acting Antiviral Agents for Chronic Hepatitis C Genotype 1 [Internet].

Murphy G, Farah B, Wong W, Krahn M, Wells G, Chen L, Kelly S, Kaunelis D, Blouin J, Lee K, Carrie A.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2014 Oct.

5.

Recent Advances in Antiviral Therapy for Chronic Hepatitis C.

Tamori A, Enomoto M, Kawada N.

Mediators Inflamm. 2016;2016:6841628. doi: 10.1155/2016/6841628. Epub 2016 Jan 31. Review.

6.

Simeprevir and Sofosbuvir (SMV-SOF) for 12 Weeks for the Treatment of Chronic Hepatitis C Genotype 1 Infection: A Real World (Transplant) Hepatology Practice Experience.

Pillai AA, Wedd J, Norvell JP, Parekh S, Cheng N, Young N, Spivey JR, Ford R.

Am J Gastroenterol. 2016 Feb;111(2):250-60. doi: 10.1038/ajg.2015.422. Epub 2016 Feb 2.

PMID:
26832650
7.

USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study.

Frankova S, Jirsa M, Merta D, Neroldova M, Urbanek P, Senkerikova R, Spicak J, Sperl J.

Ther Clin Risk Manag. 2015 Dec 17;11:1853-61. doi: 10.2147/TCRM.S94010. eCollection 2015.

8.

Hepatitis C-vírus-fertőzés: diagnosztika, antivirális terápia, kezelés utáni gondozás. Magyar konszenzusajánlás. Érvényes: 2015. szeptember 12-től.

Hunyady B, Gerlei Z, Gervain J, Horváth G, Lengyel G, Pár A, Péter Z, Rókusz L, Schneider F, Szalay F, Tornai I, Werling K, Makara M.

Orv Hetil. 2015 Dec 15;156 Suppl 2:3-24. doi: 10.1556/OH.2015.30345. Hungarian.

PMID:
26667111
9.

Chronic hepatitis C: treat or wait? A prospective study on reasons for treatment or nontreatment in the era of first-generation protease inhibitors.

Feillant M, Jézéquel C, Lison H, Delluc A, Tanné F, Le Gruyer A, Ben Ali Z, Renard I, Latournerie M, Deugnier Y, Garioud A, Cadranel JF, Guyader D, Robaszkiewicz M, Nousbaum JB.

Eur J Gastroenterol Hepatol. 2016 Feb;28(2):164-72. doi: 10.1097/MEG.0000000000000506.

PMID:
26560750
10.

Serum WFA(+) -M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C.

Ura K, Furusyo N, Ogawa E, Hayashi T, Mukae H, Shimizu M, Toyoda K, Murata M, Hayashi J.

Aliment Pharmacol Ther. 2016 Jan;43(1):114-24. doi: 10.1111/apt.13431. Epub 2015 Oct 26.

PMID:
26503582
11.

What's new in hepatitis C virus infections in children?

Pawlowska M, Domagalski K, Pniewska A, Smok B, Halota W, Tretyn A.

World J Gastroenterol. 2015 Oct 14;21(38):10783-9. doi: 10.3748/wjg.v21.i38.10783. Review.

12.

Next-Generation Regimens: The Future of Hepatitis C Virus Therapy.

Vizuete J, Hubbard H, Lawitz E.

Clin Liver Dis. 2015 Nov;19(4):707-16, vii. doi: 10.1016/j.cld.2015.06.009. Epub 2015 Jul 26. Review.

PMID:
26466657
13.

Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients.

ANRS CO13 HEPAVIH Cohort.

AIDS. 2015 Sep 10;29(14):1821-30. doi: 10.1097/QAD.0000000000000787.

PMID:
26372388
14.

Successful Treatment of Chronic Hepatitis C Infection With Direct-Acting Antivirals in a Heart Transplant Recipient: A Case Report.

Trakroo S, Qureshi K.

Transplant Proc. 2015 Sep;47(7):2295-7. doi: 10.1016/j.transproceed.2015.06.003.

PMID:
26361703
15.

An Hepatitis C Virus (HCV)/HIV Co-Infected Patient who Developed Severe Hepatitis during Chronic HCV Infection: Sustained Viral Response with Simeprevir Plus Peginterferon-Alpha and Ribavirin.

Hirashima N, Iwase H, Shimada M, Imamura J, Sugiura W, Yokomaku Y, Watanabe T.

Intern Med. 2015;54(17):2173-7. doi: 10.2169/internalmedicine.54.4344. Epub 2015 Sep 1.

16.

Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis.

Salmerón J, Vinaixa C, Berenguer R, Pascasio JM, Sánchez Ruano JJ, Serra MÁ, Gila A, Diago M, Romero-Gómez M, Navarro JM, Testillano M, Fernández C, Espinosa D, Carmona I, Pons JA, Jorquera F, Rodriguez FJ, Pérez R, Montero JL, Granados R, Fernández M, Martín AB, Muñoz de Rueda P, Quiles R; Alhambra Spanish Study Group.

World J Gastroenterol. 2015 Aug 14;21(30):9163-74. doi: 10.3748/wjg.v21.i30.9163.

17.

Serious Pulmonary Toxicity Secondary to Novel Hepatitis C Antiviral Therapy in a Liver Transplant Recipient.

Helmers RA, Byrne TJ, Wesselius LJ, Leslie KO.

Mayo Clin Proc. 2015 Sep;90(9):1294-7. doi: 10.1016/j.mayocp.2015.06.015. Epub 2015 Jul 29.

PMID:
26231293
18.

A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.

Braun DL, Rauch A, Aouri M, Durisch N, Eberhard N, Anagnostopoulos A, Ledergerber B, Müllhaupt B, Metzner KJ, Decosterd L, Böni J, Weber R, Fehr J; Swiss HIV Cohort Study.

PLoS One. 2015 Jul 15;10(7):e0133028. doi: 10.1371/journal.pone.0133028. eCollection 2015. Erratum in: PLoS One. 2015;10(8):e0135547.

19.

Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake.

Schaerer V, Haubitz S, Kovari H, Ledergerber B, Ambrosioni J, Cavassini M, Stoeckle M, Schmid P, Decosterd L, Aouri M, Böni J, Günthard HF, Furrer H, Metzner KJ, Fehr J, Rauch A; Swiss HIV Cohort Study.

HIV Med. 2015 Nov;16(10):599-607. doi: 10.1111/hiv.12269. Epub 2015 Jul 2.

PMID:
26135140
20.

Antiviral therapies for chronic hepatitis C virus infection with cirrhosis.

Nakamoto S, Kanda T, Shirasawa H, Yokosuka O.

World J Hepatol. 2015 May 18;7(8):1133-41. doi: 10.4254/wjh.v7.i8.1133. Review.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk